- Trials with a EudraCT protocol (88)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
88 result(s) found for: Lean Body Weight.
Displaying page 1 of 5.
EudraCT Number: 2012-002816-19 | Sponsor Protocol Number: Frax001 | Start Date*: 2012-10-25 |
Sponsor Name:Rijnstate Hospital | ||
Full Title: Prospective, pharmacokinetic study for determination of the relationship between lean body weight and anti-Xa activity 4 hours after subcutaneous injection of 5700 IU nadroparin in morbidly obese p... | ||
Medical condition: patients; perioperative in bariatric surgery | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-009155-37 | Sponsor Protocol Number: 2008/066/HP | Start Date*: 2010-09-07 |
Sponsor Name:CHU-HOPITAUX DE ROUEN | ||
Full Title: Evaluation of the impact of physical reconditioning associated with specific nutritional supplementation in obese patients suffering of metabolic syndrome. | ||
Medical condition: Obese patients suffering of metabolic syndrome | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004124-26 | Sponsor Protocol Number: CBYM338X2211 | Start Date*: 2017-09-16 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A randomized, subject- and investigator-blinded, placebo-controlled study to assess the safety, pharmacokinetics and efficacy of intravenous bimagrumab in overweight and obese patients with type 2 ... | |||||||||||||
Medical condition: Diabetes Mellitus, Type 2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023648-34 | Sponsor Protocol Number: HT-ANAM-301 | Start Date*: 2011-09-15 | ||||||||||||||||
Sponsor Name:Helsinn Therapeutics (U.S.), Inc. | ||||||||||||||||||
Full Title: Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer – Cachexia (NSCLC-C): A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study to Evaluate the Safety and Efficacy ... | ||||||||||||||||||
Medical condition: Non-Small Cell Lung Cancer related Cachexia (NSCLC-C) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) NL (Completed) ES (Completed) DE (Completed) CZ (Completed) IT (Completed) SI (Completed) HU (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-004104-30 | Sponsor Protocol Number: 307-MET-9002-0009 | Start Date*: 2015-04-01 |
Sponsor Name:Pharmacia & Upjohn S.A. | ||
Full Title: Treatment With Recombinant Human Growth Hormone (Genotonorm) in Children With Short Stature Secondary to a Long Term Corticoid Therapy. A Study of Efficacy and Safety | ||
Medical condition: Juvenile idiopathic arthritis (JIA) and nephrotic syndrome (NeS) | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2018-003899-13 | Sponsor Protocol Number: NL65803.078.18 | Start Date*: 2018-12-20 |
Sponsor Name: | ||
Full Title: The effect of IntraDialytic Parenteral Nutrition on nutritional status and quality of life in hemodialysis patients | ||
Medical condition: Malnutrition / Sarcopenia (loss of muscle mass) in hemodialyse patients. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-023649-31 | Sponsor Protocol Number: HT-ANAM-302 | Start Date*: 2011-07-29 | ||||||||||||||||
Sponsor Name:Helsinn Therapeutics (U.S.), Inc. | ||||||||||||||||||
Full Title: Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer – Cachexia (NSCLC-C): A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study to Evaluate the Safety and Efficacy ... | ||||||||||||||||||
Medical condition: Non-Small Cell Lung Cancer related Cachexia (NSCLC-C) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) GB (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-024342-30 | Sponsor Protocol Number: CBYM338X2202 | Start Date*: 2011-07-20 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled multi-center study of BYM338 for treatment of cachexia in patients with stage IV non-small cell lung cancer or stage III/IV adenocarcinoma of the panc... | |||||||||||||
Medical condition: Condition of cachexia in adults with stage IV metastatic non-small cell lung cancer or stage III/IV pancreatic adenocarcinoma. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) LT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000464-27 | Sponsor Protocol Number: ART27.13-100 | Start Date*: 2020-10-29 | |||||||||||
Sponsor Name:Artelo Biosciences Limited | |||||||||||||
Full Title: A Phase 1/2 Trial of the Synthetic Cannabinoid ART27.13 in Patients with Cancer Anorexia and Weight Loss | |||||||||||||
Medical condition: Cancer anorexia and weight loss | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) IE (Ongoing) NO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003432-39 | Sponsor Protocol Number: D1690L00016 | Start Date*: 2014-11-19 | |||||||||||
Sponsor Name:Dept of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University | |||||||||||||
Full Title: A 24-week, single centre, randomized, parallel-group, double-blind, placebo controlled Phase II study to evaluate the efficacy on body weight of dapagliflozin 10 mg once daily in combination with e... | |||||||||||||
Medical condition: Obesity defined as body mass index (BMI) 30-45 kg/m2 Obesity related metabolic disorders | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004729-97 | Sponsor Protocol Number: 2018-PWL | Start Date*: 2019-08-16 | |||||||||||
Sponsor Name:Dutch Growth Research Foundation | |||||||||||||
Full Title: Randomized, controlled growth hormone study in children and adolescents with a Prader-Willi-like phenotype, followed by a two year open-label growth hormone study - effects on body composition, gro... | |||||||||||||
Medical condition: Prader-Willi-like phenotype | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000677-31 | Sponsor Protocol Number: STH15216 | Start Date*: 2011-09-16 | |||||||||||
Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust | |||||||||||||
Full Title: Testosterone Replacement in Young Male cancer Survivors | |||||||||||||
Medical condition: Borderline low levels of testosterone in male cancer survivors who have previously had leukaemia, lymphoma or testicular cancer. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004332-29 | Sponsor Protocol Number: food_intake | Start Date*: 2013-12-18 |
Sponsor Name:UZLeuven | ||
Full Title: The influence of erythromycin and bitter administration on ad libitum food intake in healthy volunteers and patients | ||
Medical condition: The effect of erythromycin administration on voluntary food intake will be tested in healthy volunteers, obese patients and patients with unexplained weight loss | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-001001-28 | Sponsor Protocol Number: G200501 | Start Date*: 2006-05-04 |
Sponsor Name:GTx Inc | ||
Full Title: Double-blind, placebo controlled, Efficacy, Safety, Tolerability, and Pharmacokinetic Study of GTx-024 in Postmenopausal Females and Elderly Males | ||
Medical condition: Healthy volunteers (Postmenopausal Females and Elderly Males) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004814-84 | Sponsor Protocol Number: CS/2016/01 | Start Date*: 2016-05-18 |
Sponsor Name:Sint Antonius Hospital | ||
Full Title: Individualized dosing of aminoglycosides, quinolones and glycopeptide antibiotics in (morbidly) obese patients | ||
Medical condition: Morbid obesity | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002323-28 | Sponsor Protocol Number: prop01 | Start Date*: 2016-06-28 |
Sponsor Name:Universitair Ziekenhuis Brussel | ||
Full Title: Blood concentration and pharmacokinetic analysis of propofol following administration of single induction dose in small children | ||
Medical condition: Children scheduled for elective surgery | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000790-94 | Sponsor Protocol Number: NN9536-4999 | Start Date*: 2022-11-07 | |||||||||||
Sponsor Name:Novo Nordisk A/S | |||||||||||||
Full Title: Effect and safety of semaglutide 7.2 mg once-weekly in participants with obesity. | |||||||||||||
Medical condition: Obesity | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Ongoing) NO (Ongoing) SK (Ongoing) HU (Ongoing) BG (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002407-10 | Sponsor Protocol Number: 17/0238 | Start Date*: 2018-03-23 | ||||||||||||||||
Sponsor Name:University College London | ||||||||||||||||||
Full Title: A double-blinded, randomised, placebo-controlled trial of liraglutide 3.0 mg in patients with poor weight-loss and a suboptimal glucagon-like peptide-1 response following bariatric surgery. | ||||||||||||||||||
Medical condition: Obesity. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-004216-22 | Sponsor Protocol Number: C602 | Start Date*: 2019-09-25 | |||||||||||
Sponsor Name:Soleno Therapeutics UK Ltd. | |||||||||||||
Full Title: An Open-Label, Long-Term Safety and Efficacy Evaluation of Diazoxide Choline Controlled-Release Tablet in Patients with Prader-Willi Syndrome | |||||||||||||
Medical condition: Hyperphagia associated with Prader-Willi Syndrome (PWS) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003083-30 | Sponsor Protocol Number: PLAQHV | Start Date*: 2019-01-31 | |||||||||||
Sponsor Name:UZ Leuven | |||||||||||||
Full Title: The effect of hydroxychloroquine sulphate on hedonic food intake, appetite-related sensations and gastrointestinal hormone release in healthy female subjects | |||||||||||||
Medical condition: The study is meant to have a better understanding in obesity and how we can prevent/cure it. Therefore, the product will first be tested in healthy, lean volunteers. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.